Acadia Healthcare Company, Inc. $ACHC Shares Sold by Counterpoint Mutual Funds LLC

Counterpoint Mutual Funds LLC cut its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 57.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,483 shares of the company’s stock after selling 32,038 shares during the period. Counterpoint Mutual Funds LLC’s holdings in Acadia Healthcare were worth $549,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in ACHC. EverSource Wealth Advisors LLC lifted its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares in the last quarter. Bayforest Capital Ltd purchased a new position in Acadia Healthcare in the fourth quarter valued at approximately $52,000. GAMMA Investing LLC raised its holdings in Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Acadia Healthcare by 4,264.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares in the last quarter.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $31.91 on Friday. The firm’s fifty day simple moving average is $25.70 and its 200-day simple moving average is $21.24. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $32.82. The stock has a market capitalization of $2.93 billion, a price-to-earnings ratio of -2.61, a PEG ratio of 10.64 and a beta of 0.64. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same quarter in the prior year, the business earned $0.40 EPS. Acadia Healthcare’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on ACHC shares. UBS Group upped their target price on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. Guggenheim boosted their price target on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. Barclays raised their price objective on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. Finally, Royal Bank Of Canada lifted their target price on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $26.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.